These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 38387896)
1. [Study on the Effect and Mechanism of Tetrandrine on Bone Marrow Mesenchymal Stem Cell-Mediated Drug Resistance in Leukemia]. Zhou XY; Jin N; Chen BA Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):33-38. PubMed ID: 38387896 [TBL] [Abstract][Full Text] [Related]
2. Tetrandrine overcomes drug resistance mediated by bone marrow microenvironment by regulating the expression of P-glycoprotein in acute leukemia. Zhou X; Jin N; Chen B Hematology; 2022 Dec; 27(1):274-279. PubMed ID: 35192780 [No Abstract] [Full Text] [Related]
3. [Inducing apoptosis and reversal effect of nilotinib in combination with tetrandrine on multidrug resistance of K562/A02 cell line]. Cui TY; Chen BA; Ding JH; Gao C; Cheng J; Bao W; Zhong YJ; Shan XY; Gao F; Xia GH; Schmitt A; Schmitt M Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):28-33. PubMed ID: 21362216 [TBL] [Abstract][Full Text] [Related]
4. [Effect of tetrandrine combined with daunorubicin on expressions of P21 and P-gp in K562/A02 cells]. Chen BA; Li J; Chen J; Gao F; Wu YN; Zhu MS; Ding JH; Gao C; Sun XC; Xu WL; Wang XM Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1179-82. PubMed ID: 19840446 [TBL] [Abstract][Full Text] [Related]
5. Mechanisms of tetrandrine and 5-bromotetrandrine in reversing multidrug resistance may relate to down-regulation of multidrug resistance associated protein 7 expression. Cheng J; Dai JY; Chen BA; Cai XH; Wang S; Gao F Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Jun; 20(3):558-63. PubMed ID: 22739155 [TBL] [Abstract][Full Text] [Related]
6. [Biomolecular mechanisms of cyclosporine A, tetrandrine and their combination on the reversion of multidrug resistance in human leukemia cell line]. Chen BA; Guo JJ; Cheng J Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 Nov; 28(11):1010-3. PubMed ID: 19213345 [TBL] [Abstract][Full Text] [Related]
7. Reversal effect of PI3-K inhibitor LY294002 on P-glycoprotein-mediated multidrug resistance of human leukemia cell line K562/DNR and gastric cancer cell line SGC7901/ADR. Zhang Y; Qu XJ; Liu YP; Yang XH; Hou KZ; Teng YE; Zhang JD Ai Zheng; 2009 Feb; 28(2):97-9. PubMed ID: 19550116 [TBL] [Abstract][Full Text] [Related]
8. Apoptotic mechanism of human leukemia K562/A02 cells induced by magnetic iron oxide nanoparticles co-loaded with daunorubicin and 5-bromotetrandrin. Wang J; Chen B; Cheng J; Cai X; Xia G; Liu R; Wang X Int J Nanomedicine; 2011; 6():1027-34. PubMed ID: 21720514 [TBL] [Abstract][Full Text] [Related]
9. Effect of D, L-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol and tetrandrine on the reversion of multidrug resistance in K562/A02 cells. Chen B; Yin L; Cheng J; Ding J; Gao C; Sun Y; Zhao G; Wang J; Bao W; Xia G; Gao F; Wang X Hematology; 2011 Jan; 16(1):24-30. PubMed ID: 21269564 [TBL] [Abstract][Full Text] [Related]
10. [Effects of 5-bromotetrandrine and daunorubicin on apoptosis and expression of survivin in K562/A02 cells]. Cai XH; Chen BA; Cheng J; Wang J; Ding JH; Bao W; Zhong YJ; Gao F; Xu WL; Shen HL; Wei HL; Chen J Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):24-7. PubMed ID: 21362215 [TBL] [Abstract][Full Text] [Related]
11. [Effect of tetrandrine and droloxifene on the reversion of drug resistance of K562/A02 cell line and induction of apoptosis]. Chen B; Dong Y; Zhang P; Cheng J; Zhou Y; Sheng M; Wang T; Gao F Zhonghua Zhong Liu Za Zhi; 2002 Nov; 24(6):526-8. PubMed ID: 12667316 [TBL] [Abstract][Full Text] [Related]
12. A promising strategy for overcoming MDR in tumor by magnetic iron oxide nanoparticles co-loaded with daunorubicin and 5-bromotetrandrin. Cheng J; Wang J; Chen B; Xia G; Cai X; Liu R; Ren Y; Bao W; Wang X Int J Nanomedicine; 2011; 6():2123-31. PubMed ID: 22114476 [TBL] [Abstract][Full Text] [Related]
13. [Influence of tetrandrine on SORCIN gene expression in K562/A02 cell line]. Li J; Chen BA; Zhu MS; Gao F; Ding JH; Gao C; Sun YY; Cheng J; Wang J; Zhao G; Song HH; Ma Y; Bao W; Sun XC; Cheng HY; Xu WL; Shen HL Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):65-9. PubMed ID: 18315902 [TBL] [Abstract][Full Text] [Related]
14. Persistent reversal of P-glycoprotein-mediated daunorubicin resistance by tetrandrine in multidrug-resistant human T lymphoblastoid leukemia MOLT-4 cells. Liu ZL; Hirano T; Tanaka S; Onda K; Oka K J Pharm Pharmacol; 2003 Nov; 55(11):1531-7. PubMed ID: 14713364 [TBL] [Abstract][Full Text] [Related]
15. Reversal of multidrug resistance in xenograft nude-mice by magnetic Fe(3)O(4) nanoparticles combined with daunorubicin and 5-bromotetrandrine. Wu YN; Chen BA; Cheng J; Gao F; Xu WL; Ding JH; Gao C; Sun XC; Li GH; Chen WJ; Liu LJ; Li XM; Wang XM Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):60-4. PubMed ID: 19236748 [TBL] [Abstract][Full Text] [Related]
16. [Embelin Reverses the Multi-drug Resistance of K562/D to Daunorubicin Independently of P-gp and MDR1 mRNA]. Jiang HN; Liu ZG; Hu R Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1342-1349. PubMed ID: 29070105 [TBL] [Abstract][Full Text] [Related]
17. Daunorubicin-loaded magnetic nanoparticles of Fe(3)O(4) greatly enhance the responses of multidrug-resistant K562 leukemic cells in a nude mouse xenograft model to chemotherapy. Lai BB; Chen BA; Cheng J; Gao F; Xu WL; Ding JH; Gao C; Sun XC; Li GH; Chen WJ; Liu LJ; Li XM; Wang XM Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Apr; 17(2):345-51. PubMed ID: 19379564 [TBL] [Abstract][Full Text] [Related]
18. [Effect of Wang J; Wang ZJ; Li ZX Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):45-51. PubMed ID: 38387898 [TBL] [Abstract][Full Text] [Related]
19. Effects of imatinib and 5-bromotetrandrine on the reversal of multidrug resistance of the K562/A02 cell line. Chen BA; Shan XY; Chen J; Xia GH; Xu WL; Schmit M Chin J Cancer; 2010 Jun; 29(6):591-5. PubMed ID: 20507731 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin. Liu R; Wang Y; Li X; Bao W; Xia G; Chen W; Cheng J; Xu Y; Guo L; Chen B Drug Des Devel Ther; 2015; 9():2705-19. PubMed ID: 26045659 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]